Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by R. Hui
Economic Optimization of Flood Bypass Capacity
Get full access to this article View all available purchase options and get full access to this article. Data Availability Statement Some or all data, models, or code generated or used during the study are available from the corresponding author by request. Acknowledgments The authors are thankful for support from the Center for Watershed Sciences at UC Davis, and funding from Stephen D Bechtel Jr Foundation. References Begum, S., M. J. Stive, and J. W. Hall, eds. 2007. Vol.
Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial
Corticosteroids are commonly used topical (applied to the skin) therapies in psoriasis; although beneficial, there are concerns about their prolonged use and there is a need for effective alternatives. Many herbal remedies have been used topically, although evidence for their benefit is often limited. Indigo naturalis has been used for several years in Chinese traditional medicine; unfortunately, when taken by mouth it can cause gastro-intestinal side effects or liver damage.
治疗银屑病的青黛软膏中的靛玉红含量对比:一项随机、双盲、剂量对照试验 - Lin - 2018 - British Journal of Dermatology - Wiley Online Library
Summary??????????????????(????),??????,?????????????????????????????????????????,??????????????????????,?????,??????????????????????????,?????????????(????????)??????,??????????,??????????????????,???????????????(???)??????????????????????????????????????????? 109 ????????,???????????????? 20%????? 8 ????????????????(10 lg/g ? 200 lg/g),?????? 12 ??????????????????????????????? (PASI),????????????????200 lg/g ???????:???,56.5% ??? PASI ???? 75%,? 30.4% ??? PASI ????
437O KEYNOTE-024: Pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) as first-line therapy for advanced NSCLC with a PD-L1 tumor proportion score (TPS) ≥50%
Background: Platinum-based doublet chemo is the standard first-line therapy for advanced NSCLC without a treatable oncogenic aberration. Pembro (anti–PD-1) is approved in the US and EU for previously treated, PD-L1–expressing advanced NSCLC. KEYNOTE-024 (NCT02142738) is an open-label, phase 3 study of pembro vs platinum-doublet chemo as first-line therapy for advanced NSCLC of PD-L1 TPS ?50% without treatable EGFR mutations or ALK translocations.
471P Baseline full blood count parameters as predictors of response to PD-1 inhibition in advanced NSCLC
Background: Programmed cell death 1 (PD-1) inhibitors have demonstrated a survival advantage in advanced non-small cell lung cancer (NSCLC) with some patients achieving a durable response. However, a substantial portion of patients will not respond and, to date, a simple predictor of response has not been identified. Methods: We conducted a retrospective review of all NSCLC patients treated with single-agent PD-1 inhibitors at our institution between June 2012 and June 2016.
KEYNOTE-024: Pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) as first-line therapy for advanced NSCLC with a PD-L1 tumor proportion score (TPS) ≥50%
Background: Platinum-based doublet chemo is the standard first-line therapy for advanced NSCLC without a treatable oncogenic aberration. Pembro (anti–PD-1) is approved in the US and EU for previously treated, PD-L1–expressing advanced NSCLC. KEYNOTE-024 (NCT02142738) is an open-label, phase 3 study of pembro vs platinum-doublet chemo as first-line therapy for advanced NSCLC of PD-L1 TPS ?50% without treatable EGFR mutations or ALK translocations.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with R.
Contact R., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack